Rajnish Wellness Limited (BOM:541601)
0.5000
0.00 (0.00%)
At close: Feb 12, 2026
Rajnish Wellness Revenue
Rajnish Wellness had revenue of 232.45M INR in the quarter ending December 31, 2025, with 156.43% growth. This brings the company's revenue in the last twelve months to 455.79M, down -35.65% year-over-year. In the fiscal year ending March 31, 2025, Rajnish Wellness had annual revenue of 485.61M, down -36.67%.
Revenue (ttm)
455.79M
Revenue Growth
-35.65%
P/S Ratio
1.07
Revenue / Employee
26.81M
Employees
17
Market Cap
487.37M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 485.61M | -281.24M | -36.67% |
| Mar 31, 2024 | 766.85M | 508.59M | 196.93% |
| Mar 31, 2023 | 258.26M | -6.11M | -2.31% |
| Mar 31, 2022 | 264.37M | 130.08M | 96.86% |
| Mar 31, 2021 | 134.29M | -3.19M | -2.32% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Murae Organisor | 8.59B |
| Welcure Drugs and Pharmaceuticals | 3.66B |
| Mangalam Drugs & Organics | 2.38B |
| Godavari Drugs | 1.06B |
| Walpar Nutritions | 757.46M |
| JFL Life Sciences | 744.78M |
| Onyx Biotec | 663.87M |
| Panjon | 463.51M |